Head and Neck Squamous Cell Carcinoma (HNSCC) Unknown Status Phase 2 Trials for DB06589 (Pazopanib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01377298Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTreatment